Examples of using Vpvb in English and their translations into German
{-}
-
Colloquial
-
Official
-
Ecclesiastic
-
Medicine
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
VPvB= very persistent, very bioaccumulative.
This product does not contain any PBT or vPvB substances.
Being PBT, vPvB, or SVHC in an individual concentration ≥ 0.1Â% by weight for non-gaseous mixtures;
This substance does not meet the criteria for classification as PBT or vPvB.
Results of PBT and vPvB assessment The components in this formulation do not meet the criteria for classification as PBT or vPvB.
People also translate
This preparation doesnot meet the criteria for classification as PBT or vPvB. Hazard symbols.
The presence of CMR, PBV or vPvB substances(listed in Annex XIII) is not necessarily reported to the authority or registered;
The components in this formulation do not meet the criteria for classification as PBT or vPvB.
Information on whether the substance or mixture meets the criteria for PBT or vPvB in accordance with Annex XIII shall be provided.
Results of PBT and vPvB assessment The components in this formulation do not meet the criteria for classification as PBT or vPvB.
Substances included on this list include CMR substances in categories 1A and 1B, PBT and vPvB, and endocrine disruptors.
As is the case for persistent and bioaccumulative substances(PBT and vPvB), the wish is for endocrine disrupters to be authorised only if there is no appropriate substitution and if the socio-economic advantages are demonstrated.
The assessment only needs to address the properties that led to an authorisation being required specified in Annex XIII: CMR,PBT, vPvB etc.
The substance is persistent, bioaccumulative and toxic(PBT)or very persistent and very bioaccumulative(vPvB) in accordance with the criteria set out in Annex XIII or.
A CSA only needs to consider the steps of exposure assessment and risk characterisation ifthe substance meets the criteria for classification as dangerous or is assessed to be a PBT or vPvB.
It consists of, contains orgenerates a substance with properties meeting the criteria for being PBT or vPvB in accordance with Annex XIII to the REACH Regulation4; d.5 it has endocrine-disrupting properties; or.
The labelling of products for use by the public should also include details of any use-related risks, or at least of the presence of CMR,PBV or vPvB substances.
Apart from the rules[1] concerning the possibility to obtain authorisation according to the category of substance to be used(CMR 1 or 2,Endocrine disrupter or PBT, vPvB), a substitution plan will be required if there are appropriate alternatives or if not, if research and development studies are planned.
At the same time, the common position provides that adequate control is not a sufficient ground for granting authorisations in the case of substances that are persistent,bioaccumulative and toxic(PBT) or very persistent, very bioaccumulative vPvB.
It contains one or more active substances which fulfil the criteria for being persistent, bio-accumulative and toxic(PBT)or very persistent and very bio-accumulative(vPvB) in accordance with Annex XIII of Regulation(EC) No 1907/2006;
A hazard assessment in accordance with Sections 1 and 3 of this Annex addressing all the long-term effects and the estimation of the long-term exposure of humans and the environment as carried out in accordance with Section 5(Exposure Assessment), step 2(Exposure Estimation),cannot be carried out with sufficient reliability for substances satisfying the PBT and vPvB criteria in Annex XIII.
If the substance does not meet the classification criteria, the reason for indicating thesubstance in subsection 3.2 shall be described, such as‘non-classified vPvB substance' or‘substance with a Union workplace exposure limit.
CSA related to the identification of persistent bioaccumulative and toxic(PBT)and very persistent and very bioaccumulative(vPvB) substances have been updated.